Remove Conditions Remove Events Remove Patients
article thumbnail

Study: Cannabis Safe and Effective in Fibromyalgia Patients

NORML

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Texas NORML: Patient Lobby Day Recap

NORML

In the Texas State Capitol Building, dozens of patients joined us to ask their legislators to coauthor legislation that makes the Texas Compassionate Use Program more inclusive and effective. Patients then broke out into groups by district and went to visit their legislative offices. View pictures from the event!

Patients 182
article thumbnail

Cannabis Report FY2024 (IDPH portion)

Illinois News Joint

The focus of the subsequent three meetings was the examination of conditions under consideration for addition to the list of debilitating conditions that are qualifying for participation in the Medical Cannabis Patient Program (MCPP). Those recommendations are being reviewed by the IDPH director’s office.”

article thumbnail

MCAB recommends fourth condition, agrees more education needed

Illinois News Joint

MCAB members voted to recommend Uterine Fibroid and Painful Uterine Fibroid but did not recommend Generalized Anxiety as a qualifying debilitating condition. After back-and-forth discussion, board members first voted 7-0 to approve Uterine Fibroid as a qualifying debilitating condition. Subieta Benito abstained from the vote.

article thumbnail

Medical Cannabis Advisory Board recommends 2-of-3 new conditions

Illinois News Joint

focused discussions on whether or not to include four more new qualifying debilitating conditions for medical cannabis patients in Illinois: Ovarian Cyst, Polycystic Ovarian Syndrome, Uterine Fibroid, and Generalized Anxiety. Nichols stated, “I’m having trouble seeing this as a debilitating condition.

article thumbnail

MCAB awaits chair appointment for final decision on recommended conditions

Illinois News Joint

During the last few months, the Illinois Department of Public Health (IDPH), in conjunction with the Medical Cannabis Advisory Board (MCAB), voted to add four new recommended conditions to list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.